Recruiting

AIBehavioral AI for Peritoneal Dialysis Decision in Kidney Failure

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Urogenital Diseases+9

+ Chronic Disease

+ Female Urogenital Diseases and Pregnancy Complications

Over 18 Years
+4 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: September 2024
See protocol details

Summary

Principal SponsorScaled Insights
Study ContactStuart W Flint, PhD
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2024

Actual date on which the first participant was enrolled.

This study focuses on improving the understanding of kidney failure patients who opt for peritoneal dialysis, a treatment that uses the lining of the abdomen to filter the blood. The goal is to develop personalized nudges, or encouragements, to help patients with Chronic Kidney Disease (CKD) choose peritoneal dialysis. The study uses a Behavioral Artificial Intelligence (AI) solution from Scaled Insights to analyze patient personality traits and correlate them with their dialysis choices. The aim is to create a tool that can predict a patient's likelihood of choosing peritoneal dialysis or hemodialysis, another type of dialysis treatment. During the study, the AI system will identify personality attributes of CKD patients and group them based on their dialysis choices. Once the prediction is possible, customized nudges will be developed and tested to increase the likelihood of patients choosing peritoneal dialysis. The primary outcome of the study is to record the patient's choice of dialysis, which will be documented by their healthcare provider as part of routine care. The study hypothesizes that the AI system will successfully identify the personality traits of patients likely to opt for either peritoneal dialysis or hemodialysis, and find effective nudges to encourage CKD patients to choose peritoneal dialysis.

Official TitleUse of Behavioral Artificial Intelligence to Predict and Increase Uptake of Peritoneal Dialysis [AI-Dialysis]
NCT06533254
Principal SponsorScaled Insights
Study ContactStuart W Flint, PhD
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

3000 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesChronic DiseaseFemale Urogenital Diseases and Pregnancy ComplicationsKidney DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsUrologic DiseasesDisease AttributesRenal Insufficiency, ChronicRenal InsufficiencyFemale Urogenital DiseasesMale Urogenital Diseases

Criteria

2 inclusion criteria required to participate
Phase 1: US and UK adult patients aged 18+ years, with Chronic Kidney Disease stage 4-5.

Phase 2: US and UK adult patients aged 18+ years, with Chronic Kidney Disease stage 4-5.

2 exclusion criteria prevent from participating
Phase 1: Young people aged <18 years. People who do not have Chronic Kidney Disease. People who reside outside of the USA and UK.

Phases 2: Young people aged <18 years. People who do not have Chronic Kidney Disease stage 4-5. People who reside outside of the USA and UK.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Dallas Renal Group

Dallas, United StatesOpen Dallas Renal Group in Google Maps
Recruiting
One Study Center